Mastocytosis

• CLINICAL_TRIALS trial_result · 2025-02-24
  Clinical Trial Update: Cromoglicate in Mastocytosis [Phase 2]

  Phase 2 trial of Cromoglicate for mastocytosis conducted by LEO Pharma was terminated.

• CLINICAL_TRIALS trial_result · 2022-01-04
  Clinical Trial Update: Therapy of HES, PV, Atypical Chronic Myelocytic Leukemia (CML) or Chronic Myelomonocytic Leukemia (CMML), and Mastocytosis With Imatinib Mesylate [NA]

  Clinical trial update of imatinib mesylate for various myeloproliferative and related neoplasms including CMML, CML, polycythemia vera, hype…

• CLINICAL_TRIALS trial_result · 2021-10-20
  Clinical Trial Update: Hydroxychloroquine in Isolated Cutaneous Mastocytosis Patients or Indolent Systemic Mastocytosis With Associated Skin Involvement Patients [Phase 2, Phase 3]

  Clinical trial update for hydroxychloroquine in mastocytosis patients across Phase 2 and Phase 3.

• CLINICAL_TRIALS trial_result · 2020-04-09
  Clinical Trial Update: Mast Cell Activation Test in Allergic Disease

  Completed clinical trial evaluating a mast cell activation test in allergic diseases; results posted in 2020.

• CLINICAL_TRIALS trial_result · 2018-12-11
  Clinical Trial Update: Efficacy of AB1010 in Patients With Systemic Indolent Mastocytosis [Phase 2]

  Phase 2 clinical trial assessing the efficacy of AB1010 in patients with systemic indolent mastocytosis has completed.

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS trial_result · 2018-12-10
  Clinical Trial Update: Masitinib in Patients With Mastocytosis With Handicap and Bearing the D816V Mutation [Phase 2]

  Phase 2 clinical trial update for masitinib in patients with mastocytosis carrying the D816V mutation has completed.

• CLINICAL_TRIALS trial_result · 2016-11-03
  Clinical Trial Update: Study on Mastocytosis for Rupatadine Treatment [Phase 2, Phase 3]

  This document reports the completion of phase 2 and phase 3 trials evaluating rupatadine as a treatment for mastocytosis.

• CLINICAL_TRIALS trial_result · 2016-09-29
  Clinical Trial Update: Treatment of Indolent Systemic Mastocytosis With PA101 [Phase 2]

  A Phase 2 clinical trial evaluating PA101 for indolent systemic mastocytosis has completed.

• CLINICAL_TRIALS trial_result · 2016-01-18
  Clinical Trial Update: The Effect of Xolair ® (Omalizumab) in Mastocytosis Patients [Phase 2, Phase 3]

  Xolair (omalizumab) has been studied in patients with mastocytosis, and the Phase 2 and Phase 3 trials have completed.

• CLINICAL_TRIALS trial_result · 2008-03-04
  Clinical Trial Update: Blood Factors in Mastocytosis and Unexplained Anaphylaxis and Flushing

  A completed clinical trial sponsored by the National Institute of Allergy and Infectious Diseases studied blood factors in patients with mas…